Literature DB >> 9624417

Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer.

J S de Jong1, P J van Diest, R J Michalides, P van der Valk, C J Meijer, J P Baak.   

Abstract

BACKGROUND: In vitro studies have shown that amplification and overexpression of the cyclin D1 gene can accelerate the progress of cells through the G1 phase. Therefore, cyclin D1 may have an apoptosis inhibiting effect. The retinoblastoma (Rb) gene was shown recently to be an important regulator of apoptosis. AIMS: To evaluate whether expression of the cyclin D1 and Rb genes correlated with apoptotic counts in a group of 97 invasive breast cancers.
METHODS: Expression of the cyclin D1 and Rb genes was detected by standard immunnohistochemistry using paraffin wax embedded sections. Apoptotic cells were counted according to a strict protocol, in 10 fields of vision systematically spread over the most poorly differentiated area of the tumour, at a magnification of x630. Apoptotic cells counts were expressed as apoptotic cells/mm2.
RESULTS: Cyclin D1 overexpression was found in 49% of cases. Loss of Rb expression was found in 44% of cases, and occurred particularly in poorly differentiated tumours. Cyclin D1 and Rb expression showed a positive correlation (p = 0.003). Apoptotic counts varied from 1 to 62/mm2. There were no significant correlations between cyclin D1 overexpression and apoptotic counts in the total group or in the retinoblastoma protein (pRb) positive tumours. Loss of Rb expression also showed no correlation with apoptotic counts.
CONCLUSIONS: Cyclin D1 is frequently overexpressed in pRb positive tumours, but no evidence has been found for an anti-apoptotic effect of cyclin D1 overexpression or Rb expression in invasive breast cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9624417      PMCID: PMC395605          DOI: 10.1136/mp.51.1.30

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  54 in total

1.  p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation.

Authors:  A R Clarke; S Gledhill; M L Hooper; C C Bird; A H Wyllie
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

2.  The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.

Authors:  G Fan; X Ma; B T Kren; C J Steer
Journal:  Oncogene       Date:  1996-05-02       Impact factor: 9.867

3.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Authors:  D E Quelle; R A Ashmun; S A Shurtleff; J Y Kato; D Bar-Sagi; M F Roussel; C J Sherr
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

4.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

5.  Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.

Authors:  E Schuuring; E Verhoeven; W J Mooi; R J Michalides
Journal:  Oncogene       Date:  1992-02       Impact factor: 9.867

6.  Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2.

Authors:  A J Wagner; M B Small; N Hay
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

7.  Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts.

Authors:  M Pagano; A M Theodoras; S W Tam; G F Draetta
Journal:  Genes Dev       Date:  1994-07-15       Impact factor: 11.361

8.  Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues.

Authors:  Y Mizukami; A Nonomura; T Yamada; H Kurumaya; M Hayashi; N Koyasaki; T Taniya; M Noguchi; S Nakamura; F Matsubara
Journal:  Anticancer Res       Date:  1990 Sep-Oct       Impact factor: 2.480

9.  Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.

Authors:  C Gillett; V Fantl; R Smith; C Fisher; J Bartek; C Dickson; D Barnes; G Peters
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

10.  Inhibition of apoptosis by the retinoblastoma gene product.

Authors:  D A Haas-Kogan; S C Kogan; D Levi; P Dazin; A T'Ang; Y K Fung; M A Israel
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

View more
  3 in total

1.  p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.

Authors:  T Megha; F Ferrari; A Benvenuto; C Bellan; A V Lalinga; S Lazzi; S Bartolommei; G Cevenini; L Leoncini; P Tosi
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

2.  Number of apoptotic cells as a prognostic marker in invasive breast cancer.

Authors:  J S de Jong; P J van Diest; J P Baak
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

3.  The Analysis of bcl-2 in Association with p53 and Ki-67 in Triple Negative Breast Cancer and Other Molecular Subtypes in Ghana.

Authors:  Charity Ameh-Mensah; Babatunde Moses Duduyemi; Kweku Bedu-Addo; Elijah Atta Manu; Francis Opoku; Nicholas Titiloye
Journal:  J Oncol       Date:  2021-06-03       Impact factor: 4.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.